Health Catalyst, Inc. 2025 Annual Report – Investor Summary

Key Highlights for Investors

• Fiscal Year End: December 31, 2025
• Public Float: \$259 million as of June 30, 2025, based on Nasdaq closing price
• Trading Symbol: HCAT
• Exchange: Nasdaq Global Select Market
• Document Type: Annual Report on Form 10-K

Summary of Business Risks and Forward-Looking Statements

Health Catalyst, Inc. (“the Company”) operates in a highly competitive industry, with rapid technological changes and evolving client needs. The Company’s forward-looking statements, including predictions about future financial performance, growth, and strategic initiatives, are subject to numerous risks and uncertainties. Notable risks include:

• Intense competition in the healthcare analytics and technology sector, which could impact market share and profitability.
• Challenges in executing growth strategies, cost reduction, and restructuring initiatives.
• Potential adverse effects from macroeconomic conditions such as inflation, high interest rates, tariff uncertainties, reductions in Medicaid and research funding, and market volatility.
• Risks from natural disasters, public health crises, and regional or global conflicts (including those in the Middle East).
• Dependence on client satisfaction and contract renewals. Any decline in renewals or reduced fee levels may materially impact revenues.
• Fluctuations in operating results, which could influence share price and investor confidence.
• Interest rate risks and restrictive covenants in the term loan facility that may limit strategic flexibility.
• Potential litigation or liability if the platform fails to provide accurate information or is associated with faulty clinical decisions.
• Volatility in the common stock’s market price, which may decline for reasons unrelated to operating performance.

Investors should note that the Company’s management has no obligation to update forward-looking statements after the date of publication, except as required by law.

Operating Principles

Health Catalyst emphasizes improvement, accountability, and excellence as core operating principles. The Company is committed to:

• Enabling clients to achieve measurable clinical, financial, and operational improvements.
• Fostering long-term partnerships and prioritizing innovations that accelerate improvement.
• Attracting and retaining domain experts and leveraging analytics for sustained client success.
• Practicing accountability to stakeholders: team members, clients, patients, and shareholders.
• Making stewardship and efficient use of assets a priority.

Potential Price-Sensitive Issues for Shareholders

• Market Volatility: The report highlights that Health Catalyst’s stock price has decreased in recent periods and may continue to be volatile, influenced by both internal performance and external factors.
• Client Retention Risks: Any failure to renew contracts or expand client relationships could result in material adverse effects on revenue and share value.
• Debt and Liquidity: The Company’s term loan facility imposes restrictions that could hinder growth and operational flexibility, potentially impacting investor sentiment and share price.
• Macroeconomic and Geopolitical Risks: Continued exposure to inflation, interest rates, and global conflicts could negatively affect financial performance and share value.
• Regulatory and Legal Risks: Risks related to data use, intellectual property, and litigation could result in significant liabilities or operational constraints.

Shareholder Information

• The Company is not a well-known seasoned issuer, a voluntary filer, a shell company, an emerging growth company, or a smaller reporting company.
• All required reports and interactive data files have been submitted in compliance with SEC regulations.
• There were no corrections of financial statement errors or restatements requiring recovery analysis of incentive-based compensation for executives.
• Management’s assessment of internal controls over financial reporting has been attested to by the independent auditor.

Outlook and Guidance

Health Catalyst’s management expresses confidence in the Company’s ability to attract new clients, expand offerings, and successfully migrate clients to its new platform, Health Catalyst Ignite. However, the Company cautions that its future performance is dependent on successfully managing the risks outlined above, including maintaining client satisfaction, innovating in a competitive market, and navigating macroeconomic headwinds.

Conclusion

Overall, Health Catalyst’s 2025 Annual Report presents a company focused on improvement and client success, but facing significant industry, macroeconomic, and operational risks. Shareholders should monitor developments in client retention, debt management, and broader economic conditions as potential drivers of share price volatility in the coming year.

Disclaimer: This summary is for informational purposes only and does not constitute investment advice. Investors should review the full Health Catalyst, Inc. Annual Report on Form 10-K and consult with financial professionals before making investment decisions. The Company’s forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated.

View Health Catalyst, Inc. Historical chart here